GGrantIndex
Sort

25,944 grants matching neurodegeneration

Inorganic polyphosphate as a chaperone in aging and in neurodegenerative diseases

$239,700
Maria De La Encarnacion Solesio Torregrosa · Rutgers The State Univ Of Nj Camden · R00 · FY2021 · AG

SUMO conjugation in cell biology and Development

$239,693
Albert J Courey · University Of California Los Angeles · R01 · FY2008 · GM

Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease

$239,633
Norma Frizzell · University Of South Carolina At Columbia · R01 · FY2015 · NS

Training in Neurodegenerative Diseases

$239,629
Xiongwei Zhu · Case Western Reserve University · T32 · FY2025 · NS

GDAP1 mediated cellular damage in MLIV

$239,619
Kirill Kiselyov · University Of Pittsburgh At Pittsburgh · R21 · FY2016 · NS

Real time imaging of immune cells and glutamate dynamics by PET and metabolic MRI

$239,509
Caroline Guglielmetti · Washington University · R00 · FY2024 · AI

NSAID Inhibition Microglial Activation and AD Pathology

$239,400
University Of California Los Angeles · R01 · FY2003 · AG

NSAID Inhibition Microglial Activation and AD Pathology

$239,400
University Of California Los Angeles · R01 · FY2002 · AG

Epigenetic Regulation of Heterochromatin Condensation in Huntington's Disease

$239,380
Hoon Ryu · Boston University Medical Campus · R01 · FY2013 · NS

PHARMACOLOGICAL CORRELATES AGING AND BRAIN CELL GRAFTS

$239,350
Ann-Charlotte Esther Granholm-Bentley · University Of South Florida · P01 · FY2006 · AG

Longitudinal Measurement of Neurodegeneration in two Murine Models of Multiple Sclerosis: A Clinical and Histopathologic Validation Study

$239,332
Francesca Gilli · Dartmouth-Hitchcock Clinic · R21 · FY2021 · NS

The role of Nemo-like kinase in neurodegeneration

$239,330
Janghoo Lim · Yale University · R00 · FY2011 · NS

Development of a microbial-rich exposure regimen to accelerate translational research using mouse models of Alzheimer's Disease to humans.

$239,250
Gregorio Valdez · Brown University · R21 · FY2024 · AG

National Cohort Studies of Alzheimer's Disease, Related Dementias and Air Pollution

$239,250
Antonella Zanobetti · Harvard School Of Public Health · R01 · FY2021 · AG

Role of the MyD88-independent pathway in Alzheimers disease

$239,250
Ken-Ichiro Fukuchi · University Of Illinois At Chicago · R21 · FY2014 · AG

Cholesterol Biomarkers and Oxysterols in Multiple Sclerosis Progression

$239,250
Murali Ramanathan · State University Of New York At Buffalo · R21 · FY2016 · NS

The cell-specific neurodegenerative potential of mitochondria post-traumatic brain injury

$239,172
Volha Liaudanskaya · University Of Cincinnati · R21 · FY2025 · AG

Team science approach to integrate machine-learning models and functional genomics to study aging in the context of Alzheimer's disease

$239,122
Kristen Jennifer Brennand · Yale University · R21 · FY2024 · AG

Understanding dynamics of brain network in TDP-43 related neurodegeneration

$238,968
Rong Chen · University Of Maryland Baltimore · R21 · FY2024 · AG

SUMO conjugation in cell biology and Development

$238,941
Albert J Courey · University Of California Los Angeles · R01 · FY2009 · GM

Admin Core

$238,925
Douglas Hamilton Smith · University Of Pennsylvania · U54 · FY2023 · NS

Project 3 - Defining the role of ribosome protein composition in regulating the selective translation of pro-longevity genes

$238,870
Jarod Alton Rollins · Mount Desert Island Biological Lab · P20 · FY2018 · GM

HTLV Deregulation of CD40(L) in Cancer&Neurodegeneration

$238,817
Edward W Harhaj · University Of Miami School Of Medicine · R01 · FY2007 · CA

Discovery of Small Molecule Inhibitors of the Classical Complement Pathway Using Cheminformatics

$238,750
Brian Geisbrecht · Kansas State University · R21 · FY2018 · NS

SWS/NTE function in neurodegeneration and axonopathy

$238,687
Doris Kretzschmar · Oregon Health & Science University · R01 · FY2006 · NS